This work is licensed under the Creative Commons Attribution 4.0 International License.
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022; 72: 7–33. doi: 10.3322/caac.21708SiegelRLMillerKDFuchsHEJemalACancer statistics, 2022CA Cancer J Clin20227273310.3322/caac.21708Open DOISearch in Google Scholar
Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM, et al. Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med 2019; 381: 2091–102. doi: 10.1056/NEJMoa1903986BakkerMFde LangeSVPijnappelRMMannRMPeetersPHMMonninkhofEMSupplemental MRI screening for women with extremely dense breast tissueN Engl J Med2019381209110210.1056/NEJMoa1903986Open DOISearch in Google Scholar
Sumkin JH, Berg WA, Carter GJ, Bandos AI, Chough DM, Ganott MA, et al. Diagnostic performance of MRI, molecular breast imaging, and contrast-enhanced mammography in women with newly diagnosed breast cancer. Radiology 2019; 293: 531–40. doi: 10.1148/radiol.2019190887SumkinJHBergWACarterGJBandosAIChoughDMGanottMADiagnostic performance of MRI, molecular breast imaging, and contrast-enhanced mammography in women with newly diagnosed breast cancerRadiology20192935314010.1148/radiol.2019190887Open DOISearch in Google Scholar
Jahani N, Cohen E, Hsieh MK, Weinstein SP, Pantalone L, Hylton N, et al. Prediction of treatment response to neoadjuvant chemotherapy for breast cancer via early changes in tumor heterogeneity captured by DCE-MRI registration. Sci Rep 2019; 9: 12114. doi: 10.1038/s41598-019-48465-xJahaniNCohenEHsiehMKWeinsteinSPPantaloneLHyltonNPrediction of treatment response to neoadjuvant chemotherapy for breast cancer via early changes in tumor heterogeneity captured by DCE-MRI registrationSci Rep201991211410.1038/s41598-019-48465-xOpen DOISearch in Google Scholar
Zanello PA, Robim AF, Oliveira TM, Elias Junior J, Andrade JM, Monteiro CR, et al. Breast ultrasound diagnostic performance and outcomes for mass lesions using Breast Imaging Reporting and Data System category 0 mammogram. Clinics 2011; 66: 443–8. doi: 10.1590/s1807-59322011000300014ZanelloPARobimAFOliveiraTMElias JuniorJAndradeJMMonteiroCRBreast ultrasound diagnostic performance and outcomes for mass lesions using Breast Imaging Reporting and Data System category 0 mammogramClinics201166443810.1590/s1807-59322011000300014Open DOISearch in Google Scholar
McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Murray DL, Thielen KR, et al. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 2015; 275: 772–82. doi: 10.1148/radiol.15150025McDonaldRJMcDonaldJSKallmesDFJentoftMEMurrayDLThielenKRIntracranial gadolinium deposition after contrast-enhanced MR imagingRadiology20152757728210.1148/radiol.15150025Open DOISearch in Google Scholar
Kim HJJon. Variability in quantitative DCE-MRI: sources and solutions. J Nat Sci 2018; 4: e484.KimHJJon.Variability in quantitative DCE-MRI: sources and solutionsJ Nat Sci20184e484Search in Google Scholar
Alkhunizi SM, Fakhoury M, Abou-Kheir W, Lawand N. Gadolinium retention in the central and peripheral nervous system: implications for pain, cognition, and neurogenesis. Radiology 2020; 297: 407–16. doi: 10.1148/radiol.2020192645AlkhuniziSMFakhouryMAbou-KheirWLawandNGadolinium retention in the central and peripheral nervous system: implications for pain, cognition, and neurogenesisRadiology20202974071610.1148/radiol.2020192645Open DOISearch in Google Scholar
Benzon HT, Maus TP, Kang HR, Provenzano DA, Bhatia A, Diehn F, et al. The use of contrast agents in interventional pain procedures: a multispecialty and multisociety practice advisory on nephrogenic systemic fibrosis, gadolinium deposition in the brain, encephalopathy after unintentional intrathecal gadolinium injection, and hypersensitivity reactions. Anesth Analg 2021; 133: 535–52. doi: 10.1213/ANE.0000000000005443BenzonHTMausTPKangHRProvenzanoDABhatiaADiehnFThe use of contrast agents in interventional pain procedures: a multispecialty and multisociety practice advisory on nephrogenic systemic fibrosis, gadolinium deposition in the brain, encephalopathy after unintentional intrathecal gadolinium injection, and hypersensitivity reactionsAnesth Analg20211335355210.1213/ANE.0000000000005443Open DOISearch in Google Scholar
Ward KM, Aletras AH, Balaban RS. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000; 143: 79–87. doi: 10.1006/jmre.1999.1956WardKMAletrasAHBalabanRSA new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST)J Magn Reson2000143798710.1006/jmre.1999.1956Open DOISearch in Google Scholar
Zhou J, Payen JF, Wilson DA, Traystman RJ, van Zijl PC. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 2003; 9: 1085–90. doi: 10.1038/nm907ZhouJPayenJFWilsonDATraystmanRJvan ZijlPCUsing the amide proton signals of intracellular proteins and peptides to detect pH effects in MRINat Med2003910859010.1038/nm907Open DOISearch in Google Scholar
Chen Z, Han Z, Liu G. Repurposing clinical agents for chemical exchange saturation transfer magnetic resonance imaging: current status and future perspectives. Pharmaceuticals 2020; 14: 11. doi: 10.3390/ph14010011ChenZHanZLiuGRepurposing clinical agents for chemical exchange saturation transfer magnetic resonance imaging: current status and future perspectivesPharmaceuticals2020141110.3390/ph14010011Open DOISearch in Google Scholar
Zhou J, Heo HY, Knutsson L, van Zijl PCM, Jiang S. APT-weighted MRI: Techniques, current neuro applications, and challenging issues. J Magn Reson Imaging 2019; 50: 347–64. doi: 10.1002/jmri.26645ZhouJHeoHYKnutssonLvan ZijlPCMJiangSAPT-weighted MRI: Techniques, current neuro applications, and challenging issuesJ Magn Reson Imaging2019503476410.1002/jmri.26645Open DOISearch in Google Scholar
Meng N, Wang XJ, Sun J, Huang L, Wang Z, Wang KY. Comparative study of amide proton transfer-weighted imaging and intravoxel incoherent motion imaging in breast cancer diagnosis and evaluation. J Magn Reson Imaging 2020; 52: 1175–86. doi: 10.1002/jmri.27190MengNWangXJSunJHuangLWangZWangKYComparative study of amide proton transfer-weighted imaging and intravoxel incoherent motion imaging in breast cancer diagnosis and evaluationJ Magn Reson Imaging20205211758610.1002/jmri.27190Open DOISearch in Google Scholar
Zaric O, Farr A, Poblador Rodriguez E, Mlynarik V, Bogner W, Gruber S. 7T CEST MRI: A potential imaging tool for the assessment of tumor grade and cell proliferation in breast cancer. Magn Reson Imaging 2019; 59: 77–87. doi: 10.1016/j.mri.2019.03.004ZaricOFarrAPoblador RodriguezEMlynarikVBognerWGruberS7T CEST MRI: A potential imaging tool for the assessment of tumor grade and cell proliferation in breast cancerMagn Reson Imaging201959778710.1016/j.mri.2019.03.004Open DOISearch in Google Scholar
Meng N, Wang X, Sun J, Han D, Bai Y, Wei W. A comparative study of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in the diagnosis and evaluation of breast cancer. Eur Radiol 2021; 31: 1707–17. doi: 10.1007/s00330-020-07169-xMengNWangXSunJHanDBaiYWeiWA comparative study of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in the diagnosis and evaluation of breast cancerEur Radiol20213117071710.1007/s00330-020-07169-xOpen DOISearch in Google Scholar
Dula AN, Arlinghaus LR, Dortch RD, Dewey BE, Whisenant JG, Ayers GD. Amide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy response. Magn Reson Med 2013; 70: 216–24. doi: 10.1002/mrm.24450DulaANArlinghausLRDortchRDDeweyBEWhisenantJGAyersGDAmide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy responseMagn Reson Med2013702162410.1002/mrm.24450Open DOISearch in Google Scholar
Togao O, Yoshiura T, Keupp J, Hiwatashi A, Yamashita K, Kikuchi K, et al. Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. Neuro Oncol 2014; 16: 441–8. doi: 10.1093/neuonc/not158TogaoOYoshiuraTKeuppJHiwatashiAYamashitaKKikuchiKAmide proton transfer imaging of adult diffuse gliomas: correlation with histopathological gradesNeuro Oncol201416441810.1093/neuonc/not158Open DOISearch in Google Scholar
Hammond ME. Commentary: improving breast cancer testing for patients-the secret sauce is collaboration. J Oncol Pract 2010; 6: 198. doi: 10.1200/JOP.777012HammondMECommentary: improving breast cancer testing for patients-the secret sauce is collaborationJ Oncol Pract2010619810.1200/JOP.777012Open DOISearch in Google Scholar
Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol 2013; 31: 3997–4013. doi: 10.5858/arpa.2013-0953-SAWolffACHammondMEHicksDGDowsettMMcShaneLMAllisonKHRecommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateJ Clin Oncol2013313997401310.5858/arpa.2013-0953-SAOpen DOISearch in Google Scholar
Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thürlimann B, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 2013; 24: 2206–23. doi: 10.1093/annonc/mdt303GoldhirschAWinerEPCoatesASGelberRDPiccart-GebhartMThürlimannBPersonalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Ann Oncol20132422062310.1093/annonc/mdt303Open DOISearch in Google Scholar
Guo Z, Qin X, Mu R, Lv J, Meng Z, Zheng W, et al. Amide proton transfer could provide more accurate lesion characterization in the transition zone of the prostate. J Magn Reson Imaging. 2022; 56: 1311–9. doi: 10.1002/jmri.28204GuoZQinXMuRLvJMengZZhengWAmide proton transfer could provide more accurate lesion characterization in the transition zone of the prostateJ Magn Reson Imaging2022561311910.1002/jmri.28204Open DOISearch in Google Scholar
Yang L, Wang L, Tan Y, Dan H, Xian P, Zhang Y, et al. Amide proton transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study. Cancer Imaging 2023; 23: 3. doi: 10.1186/s40644-022-00515-wYangLWangLTanYDanHXianPZhangYAmide proton transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort studyCancer Imaging202323310.1186/s40644-022-00515-wOpen DOISearch in Google Scholar
Tian S, Chen A, Li Y, Wang N, Ma C, Lin L, et al. The combined application of amide proton transfer imaging and diffusion kurtosis imaging for differentiating stage Ia endometrial carcinoma and endometrial polyps. Magn Reson Imaging 2023; 99: 67–72. doi: 10.1016/j.mri.2022.12.026TianSChenALiYWangNMaCLinLThe combined application of amide proton transfer imaging and diffusion kurtosis imaging for differentiating stage Ia endometrial carcinoma and endometrial polypsMagn Reson Imaging202399677210.1016/j.mri.2022.12.026Open DOISearch in Google Scholar
Li Y, Lin CY, Qi YF, Wang XQ, Chen B, Zhou HL, et al. Non-invasive differentiation of endometrial adenocarcinoma from benign lesions in the uterus by utilization of amide proton transfer-weighted MRI. Mol Imaging Biol 2021; 23: 446–55. doi: 10.1007/s11307-020-01565-xLiYLinCYQiYFWangXQChenBZhouHLNon-invasive differentiation of endometrial adenocarcinoma from benign lesions in the uterus by utilization of amide proton transfer-weighted MRIMol Imaging Biol2021234465510.1007/s11307-020-01565-xOpen DOISearch in Google Scholar
Loi L, Zimmermann F, Goerke S, Korzowski A, Meissner JE, Deike-Hofmann K, et al. Relaxation-compensated CEST (chemical exchange saturation transfer) imaging in breast cancer diagnostics at 7T. Eur J Radiol 2020; 129: 109068. doi: 10.1016/j.ejrad.2020.109068LoiLZimmermannFGoerkeSKorzowskiAMeissnerJEDeike-HofmannKRelaxation-compensated CEST (chemical exchange saturation transfer) imaging in breast cancer diagnostics at 7TEur J Radiol202012910906810.1016/j.ejrad.2020.109068Open DOISearch in Google Scholar
Walker DT, Davenport MS, McGrath TA, McInnes MDF, Shankar T, Schieda N. Breakthrough hypersensitivity reactions to gadolinium-based contrast agents and strategies to decrease subsequent reaction rates: a systematic review and meta-analysis. Radiology 2020; 296: 312–21. doi: 10.1148/radiol.2020192855WalkerDTDavenportMSMcGrathTAMcInnesMDFShankarTSchiedaNBreakthrough hypersensitivity reactions to gadolinium-based contrast agents and strategies to decrease subsequent reaction rates: a systematic review and meta-analysisRadiology20202963122110.1148/radiol.2020192855Open DOISearch in Google Scholar
Alabousi M, Davenport MS. Use of intravenous gadolinium-based contrast media in patients with kidney disease and the risk of nephrogenic systemic fibrosis: Radiology in training. Radiology 2021; 300: 279–84. doi: 10.1148/radiol.2021210044AlabousiMDavenportMSUse of intravenous gadolinium-based contrast media in patients with kidney disease and the risk of nephrogenic systemic fibrosis: Radiology in trainingRadiology20213002798410.1148/radiol.2021210044Open DOISearch in Google Scholar
Bhargava V, Singh K, Meena P, Sanyal R. Nephrogenic systemic fibrosis: a frivolous entity. World J Nephrol 2021; 10: 29–36. doi: 10.5527/wjn.v10.i3.29BhargavaVSinghKMeenaPSanyalRNephrogenic systemic fibrosis: a frivolous entityWorld J Nephrol202110293610.5527/wjn.v10.i3.29Open DOISearch in Google Scholar
Tweedle MF. Gadolinium retention in human brain, bone, and skin. Radiology 2021; 300: 570–1. doi: 10.1148/radiol.2021210957TweedleMFGadolinium retention in human brain, bone, and skinRadiology2021300570110.1148/radiol.2021210957Open DOISearch in Google Scholar
Liu Z, Wen J, Wang M, Ren Y, Yang Q, Qian L, et al. Breast amide proton transfer imaging at 3 T: diagnostic performance and association with pathologic characteristics. J Magn Reson Imaging 2022; 57: 824–33. doi: 10.1002/jmri.28335LiuZWenJWangMRenYYangQQianLBreast amide proton transfer imaging at 3 T: diagnostic performance and association with pathologic characteristicsJ Magn Reson Imaging2022578243310.1002/jmri.28335Open DOISearch in Google Scholar
Zhang N, Kang J, Wang H, Liu A, Miao Y, Ma X, et al. Differentiation of fibroadenomas versus malignant breast tumors utilizing three-dimensional amide proton transfer weighted magnetic resonance imaging. Clin Imaging 2022; 81: 15–23. doi: 10.1016/j.clinimag.2021.09.002ZhangNKangJWangHLiuAMiaoYMaXDifferentiation of fibroadenomas versus malignant breast tumors utilizing three-dimensional amide proton transfer weighted magnetic resonance imagingClin Imaging202281152310.1016/j.clinimag.2021.09.002Open DOISearch in Google Scholar
Lin Z, Zhang X, Guo L, Wang K, Jiang Y, Hu X, Huang Y, et al. Clinical feasibility study of 3D intracranial magnetic resonance angiography using compressed sensing. J Magn Reson Imaging 2019; 50: 1843–51. doi: 10.1002/jmri.26752LinZZhangXGuoLWangKJiangYHuXHuangYClinical feasibility study of 3D intracranial magnetic resonance angiography using compressed sensingJ Magn Reson Imaging20195018435110.1002/jmri.26752Open DOISearch in Google Scholar
Zhang S, Keupp J, Wang X, Dimitrov I, Madhuranthakam AJ, Lenkinski RE, et al. Z-spectrum appearance and interpretation in the presence of fat: influence of acquisition parameters. Magn Reson Med 2018; 79: 2731–7. doi: 10.1002/mrm.26900ZhangSKeuppJWangXDimitrovIMadhuranthakamAJLenkinskiREZ-spectrum appearance and interpretation in the presence of fat: influence of acquisition parametersMagn Reson Med2018792731710.1002/mrm.26900Open DOISearch in Google Scholar
Strigel RM, Burnside ES, Elezaby M, Fowler AM, Kelcz F, Salkowski LR, et al. Utility of BI-RADS assessment category 4 subdivisions for screening breast MRI. AJR Am J Roentgenol 2017; 208: 1392–9. doi: 10.2214/AJR.16.16730StrigelRMBurnsideESElezabyMFowlerAMKelczFSalkowskiLRUtility of BI-RADS assessment category 4 subdivisions for screening breast MRIAJR Am J Roentgenol20172081392910.2214/AJR.16.16730Open DOISearch in Google Scholar